A detailed history of Optivise Advisory Services LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Optivise Advisory Services LLC holds 1,812 shares of JNJ stock, worth $261,779. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,812
Holding current value
$261,779
% of portfolio
0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$145.48 - $167.38 $263,609 - $303,292
1,812 New
1,812 $294 Million
Q2 2024

Nov 14, 2024

BUY
$144.38 - $157.78 $38,405 - $41,969
266 Added 14.68%
2,078 $304 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Optivise Advisory Services LLC Portfolio

Follow Optivise Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optivise Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optivise Advisory Services LLC with notifications on news.